INVO Bioscience Inc
INVO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.25M
Close$
Share Statistics
| Market cap | $3.25 Million |
|---|---|
| Enterprise Value | $689.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-214.64 |
| Beta | 1.44 |
| Outstanding Shares | 117,083,000 |
Return
| Return on Equity | -89.70% |
|---|---|
| Return on Assets | -54.66% |
| Return on Invested Capital | -41.11% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.05 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | -0.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 8.11 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 17, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NAYA Biosciences, Inc. Common Stock
33 employees
CEO: Steven M. Shum INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fert...